Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Blood biomarker profiles in young-onset neurocognitive disorders: A cohort study

17 Jan 2025

Abstract excerpt

Introduction: Young-onset neurocognitive symptoms result from a heterogeneous group of neurological and psychiatric disorders which present a diagnostic challenge. To identify such factors, we analysed the Biomarkers in Younger-Onset Neurocognitive Disorders cohort, a study of individuals <65 years old presenting with neurocognitive symptoms for a diagnosis and who have undergone cognitive and biomarker analyses....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Dementia and Cognitive Impairment Research
Share to S100 Proteins and Annexins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39825484
DOI: 10.1177/00048674241312805

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Blood biomarker profiles in young-onset neurocognitive disorders: A cohort studyPMID 39825484Read ↗

Blood biomarker profiles in young-onset neurocognitive disorders: a cohort studySemantic proximity Read ↗

Pre-Diagnostic Cognitive and Functional Impairment in Multiple Sporadic Neurodegenerative DiseasesSemantic proximity Read ↗

Impact of genetic predisposition to late-onset neurodegenerative diseases on early life outcomes and brain structure.Semantic proximity Read ↗

Impact of genetic predisposition to late-onset neurodegenerative diseases on early life outcomes and brain structureSemantic proximity Read ↗

Abnormalities in core AD biomarkers precede inflammatory and glial markers in CSF in Autosomal Dominant Alzheimer’s DiseaseSemantic proximity Read ↗

Alzheimer’s disease biomarker profiling in a memory clinic cohort without common comorbiditiesSemantic proximity Read ↗

Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans.Semantic proximity Read ↗

Associations of plasma biomarkers with age in the presenilin-1 E280A autosomal dominant Alzheimer's disease kindred.Semantic proximity Read ↗

New insights into atypical Alzheimer's disease in the era of biomarkersSemantic proximity Read ↗

Predicting Alzheimer’s Disease Phenotypes With Aging Clocks: An Exploratory AnalysisSemantic proximity Read ↗

Plasma biomarker trajectories: Impact of AD genetic risk and clinical progressionSemantic proximity Read ↗

Systematic proteomics in Autosomal dominant Alzheimer’s disease reveals decades-early changes of CSF proteins in neuronal death, and immune pathwaysSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.